CryoPort Q4 Earnings Call Highlights [Yahoo! Finance]
CryoPort, Inc. (CYRX)
NASDAQ:AMEX Investor Relations:
ir.cryoport.com
Company Research
Source: Yahoo! Finance
by revenue above prior guidance, continued commercial cell and gene therapy momentum, and further steps toward profitability. Fiscal 2025 results and mix For the full year, CryoPort posted revenue from continuing operations of $176.2 million , which CEO Jerrell Shelton said exceeded the high end of the company's prior guidance. Shelton also pointed to “double-digit” revenue growth in the fourth quarter, driven by expanding commercial cell and gene therapy activity. ? Defense Stocks Are Soaring—AeroVironment's Earnings Could Close the Gap Commercial cell and gene therapy support revenue increased 29% year-over-year to a record $33.4 million in fiscal 2025, and commercial revenue represented 20% of overall revenue in the fourth quarter, according to management. Clinical trial revenue grew 14% year-over-year to $47.1 million During the call, the company reiterated that, due to the strategic partnership with DHL and the sale of CRYOPDP, the CRYOPDP business is now presented as d
Show less
Read more
Impact Snapshot
Event Time:
CYRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CYRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CYRX alerts
High impacting CryoPort, Inc. news events
Weekly update
A roundup of the hottest topics
CYRX
News
- CryoPort (CYRX) had its price target raised by Needham & Company LLC from $12.00 to $13.00. They now have a "buy" rating on the stock.MarketBeat
- CryoPort Inc (CYRX) Q4 2025 Earnings Call Highlights: Record Growth in Cell and Gene Therapy Revenue [Yahoo! Finance]Yahoo! Finance
- Cryoport (CYRX) Q4 2025 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial Results [Yahoo! Finance]Yahoo! Finance
- Cryoport Reports Fourth Quarter and Full-Year 2025 Financial ResultsPR Newswire
CYRX
Earnings
- 3/3/26 - Miss
CYRX
Sec Filings
- 3/5/26 - Form 10-K
- 3/3/26 - Form 8-K
- 2/17/26 - Form SCHEDULE
- CYRX's page on the SEC website